Kebotix News

Valqua Partners with Kebotix to Transform Materials Innovation

Valqua Partners with Kebotix to Transform Materials Innovation

On the heels of a successful six-month proof-of-concept (POC), as of March 2022, the ink is now dry on a three-year deal that will see Valqua, LTD transform its research and development (R&D) process by partnering with Kebotix, the MIT-connected startup ushering in a new age of materials discovery with artificial intelligence (AI), machine learning, and robotics.

News

Kebotix, University of Toronto Partner on OLEDs R&D

Kebotix, University of Toronto Partner on OLEDs R&D

Kebotix, a technology platform company for new chemicals and materials, is partnering with the University of Toronto to evaluate a new class of molecules for organic light-emitting diodes – or OLEDs – developed and patented by the university.

News

Kebotix Tapped by EPA to Develop Safe Pigments

Kebotix Tapped by EPA to Develop Safe Pigments

The U.S. Environmental Protection Agency (EPA) is funding Kebotix to develop safe diarylide pigment alternatives using the company’s platform that accelerates discovery of new chemicals through artificial intelligence, machine learning and robotics. Today’s announcement by the Cambridge, Mass.-based technology company follows the EPA’s news of funding being allocated across 30 American companies to develop solutions for global environmental and public health problemsthrough innovative environmental technologies. Kebotix’s program, within the “Safer Chemicals” category, is for use of a machine-learning platform to develop diarylide pigment alternatives that do not produce polychlorinated biphenyls (PCBs) and other toxic byproducts.

News

Kebotix, SCM Partner to Advance Materials Innovation

Kebotix, SCM Partner to Advance Materials Innovation

Capitalizing on each other’s areas of expertise to advance materials innovation, Kebotix, a U.S.-based technology platform company that transforms discovery of new chemicals and materials through AI and robotics, and SCM, a Netherlands-based computational chemistry software company specializing in accurate property prediction methods through atomistic modeling, have announced a strategic partnership.

The collaboration between Kebotix and SCM is intended to enable innovative customers to drastically scale up and computationally screen far greater quantities of molecules and materials than via today’s laborious and costly norm of trial and error.

The two companies believe that integrating Kebotix’s platform with SCM’s software makes for a unique and powerful combination that will spawn faster and cost-effective new materials for the benefit of a host of industries and a world in need of sustainable solutions to life-threatening challenges.

News

Kebotix on Cusp of ‘Promising’ OLED Breakthrough

Kebotix on Cusp of ‘Promising’ OLED Breakthrough

Tapping into its proprietary closed-loop innovation platform that accelerates discovery, Kebotix built a pipeline for smart design of OLED emitter molecules. The pipeline, spawned by a Small Business Innovation Research grant from the U.S. Department of Energy, leverages the ability of AI to learn chemical intuition by analyzing huge amounts of data simultaneously and synergistically with the oversight of science experts. In less than six months several new classes of candidate molecules were discovered and developed into device prototypes.

Kebotix is targeting early- to mid-2022 for when these molecules will be ready to test with manufacturing partners interested in being early adopters of next-generation, commercially viable technology that seems to never stop advancing at Kebotix.

News

Kebotix, Mitsubishi Chemical Join Forces in Tackling Toxicity

Kebotix, Mitsubishi Chemical Join Forces in Tackling Toxicity

Mitsubishi Chemical Corporation has selected Kebotix, a U.S.-based technology platform company for new chemicals and materials, to expand its long-standing effort to solve environmental problems with greener chemistry while still providing a diverse range of products.

News

Finding ‘Needle in Haystack’ Becoming Routine at Kebotix

Finding ‘Needle in Haystack’ Becoming Routine at Kebotix

When you’re in the business of creating new, disruptive chemistries and materials at a rapid pace while reducing costs, beating tremendous odds to discover a molecule that could spawn new commercial markets is both exciting and expected.

News

MIT’s Connor Coley Joins Kebotix Advisory Panel

MIT’s Connor Coley Joins Kebotix Advisory Panel

Connor Coley, who joined MIT’s Department of Chemical Engineering as an assistant professor one year after being named to Forbes’ “30 under 30”

CONTACT US

Get in touch with us to accelerate your R&D.

Get in touch with us to accelerate your R&D.